Cargando…
A Panel of E2F Target Gene Signature Predicting the Prognosis of Hepatocellular Carcinoma
Hepatocellular carcinoma is one of the most malignant tumors, and the therapeutic effects of traditional treatments are poor. It is urgent to explore and identify new biomarkers and therapeutic targets to develop novel treatments which are individualized and effective. Three hallmarks, including E2F...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110819/ https://www.ncbi.nlm.nih.gov/pubmed/35591857 http://dx.doi.org/10.3389/fgene.2022.879299 |